Showing results (1371-1380 of 1,826) with videos related to
Sort By:
Pageof 183
Frontiers in Immunology|July 3, 2025
High NK cell counts at day 90 predict improved survival in event-free patients after T-cell depleted allogeneic stem cell transplantationAndrej Pešić, Nevena Bešević, Nicolaus Kröger, et al.Bone Marrow Transplantation|March 30, 2024
Allogeneic hematopoietic cell transplantation for older patients with AML with active disease. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Myriam Labopin, Nicolaus Kröger, et al.Blood|October 7, 2006
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantationDjordje Atanackovic, Julia Arfsten, Yanran Cao, et al.Haematologica|August 3, 2014
Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working PartyFrancesco Onida, Ronald Brand, Anja van Biezen, et al.Bone Marrow Transplantation|May 4, 2018
Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantationMohamad Mohty, Rafael F Duarte, Jurgen Kuball, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 3, 2024
Auto-contouring of cardiac substructures for Stereotactic arrhythmia radioablation (STAR): A STOPSTORM.eu consortium studyLuuk H G van der Pol, Oliver Blanck, Melanie Grehn, et al.Hemasphere|October 23, 2024
Long-term outcome of 2-year survivors after allogeneic hematopoietic cell transplantation for acute leukemiaMarion Larue, Myriam Labopin, Thomas Schroeder, et al.Leukemia|March 28, 2024
ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2023
Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working PartyAli Bazarbachi, Myriam Labopin, Tobias Gedde-Dahl, et al.Cancer|June 3, 2023
Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia-Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party studyRama Al Hamed, Maud Ngoya, Jacques-Emmanuel Galimard, et al.Pageof 183